Intracranial arterial stenting plus aggressive medical management increases stroke risk

Current recommendations from the American Heart Association and the American Stroke Association classify percutaneous transluminal angioplasty with stenting (PTAS) as an investigational intervention with unknown utility for patients with transient ischemic attack or stroke.